LAURIE BRESEE: Open Payments
NPI 1174004659 · FAIRFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,335 in 55 payments from 25 companies in 2025. Trend: 2023 $4,411 · 2024 $4,325 · 2025 $1,335
Food & beverage: $1,335
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $265 |
| PFIZER INC. | 8 | $135 |
| Merck Sharp & Dohme LLC | 3 | $90 |
| Genentech USA, Inc. | 3 | $79 |
| ABBVIE INC. | 3 | $75 |
| Lilly USA, LLC | 3 | $74 |
| E.R. Squibb & Sons, L.L.C. | 2 | $55 |
| Celgene Corporation | 2 | $51 |
| SpringWorks Therapeutics, Inc. | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
Products named: ENHERTU, KEYTRUDA, LYNPARZA, VERZENIO, Venclexta, OPDIVO, Xtandi, REBLOZYL.
Industry payments across CA — which companies pay providers there.
